Find A Physician
Return to Edward S. Harkness Eye Institute Overview
More on Edward S. Harkness Eye Institute
Hospital News
Return to Edward S. Harkness Eye Institute Overview
More on Edward S. Harkness Eye Institute
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Coping With Chronic Cancer Pain
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- New Book by Weill Cornell Psychiatrist Offers Insight and Hope for "Surviving Cancer Emotionally"
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- The Seventh Issue of Cancer Prevention Has Arrived!
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- Two Novel Biologics Studied for Multiple Myeloma
- Weill Cornell Researchers Announce New Gene Therapy Strategy To Promote Hair Growth
Research and Clinical Trials
Return to Edward S. Harkness Eye Institute Overview
More on Edward S. Harkness Eye Institute
Health Library
Return to Edward S. Harkness Eye Institute Overview
More on Edward S. Harkness Eye Institute
Clinical Services
Return to Edward S. Harkness Eye Institute Overview
More on Edward S. Harkness Eye Institute
- Bladder Cancer
- Blood Cancer
- Brain Cancer
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Eye Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Head and Neck Surgery
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Lung Cancer
- Mesothelioma
- Oncology (Cancer)
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
Edward S. Harkness Eye Institute
NewYork-Presbyterian/Columbia is a regional referral center for cancer of the eye; its Harkness Eye Institute is a member of the International Orbit Society--a study group that sponsors multicenter clinical trials. Through a multidisciplinary Skull Base Surgery team, the expertise of NewYork-Presbyterian/Columbia's ophthalmologists, neurosurgeons, otolaryngologists, plastic surgeons, radiation oncologists and interventional neuroradiologists combine their expertise to diagnose and treat cancers involving the orbit (bony structure containing the eye), as well as those involving the brain and paraorbital sinuses.
Hospital News
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma More
